Rowestil Consulting GmbH

Tridek-One is a biotech start-up developing first-in-class CD31 agonist modalities designed to restore the immune balance.

Life Science Cares Switzerland uses the innovation, financial and human resources of the life science industry to support local charitable projects. Main focus is promoting educational equity by providing young people from socially disadvantaged backgrounds with opportunities in our industry.

XEMPERIA, a spin-off from the University of Fribourg, is pioneering a groundbreaking approach to blood testing that leverages the body's immune response to detect breast cancer at its earliest and most treatable stage.